Coronary 18F-Sodium Fluoride Uptake Predicts Outcomes in Patients With Coronary Artery Disease
Jacek Kwieciński(MACOM (United States)), Marc R. Dweck(British Heart Foundation), Michelle C. Williams(British Heart Foundation), Damini Dey(Cedars-Sinai Medical Center), Sebastien Cadet(Cedars-Sinai Medical Center), Alastair J. Moss(MACOM (United States)), Edwin J.R. van Beek(University of Edinburgh), David E. Newby(British Heart Foundation), Nikhil Joshi(University of Edinburgh), Piotr J. Slomka(Cedars-Sinai Medical Center), Philip D Adamson(MACOM (United States)), Daniel S. Berman(Cedars-Sinai Medical Center), Evangelos Tzolos(Cedars-Sinai Medical Center)
Cited by 148
Related Papers
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
|The Lancet|2013|942
Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure
|Particle and Fibre Toxicology|2005|929
Prognostic Value of Cardiac Risk Factors and Coronary Artery Calcium Screening for All-Cause Mortality
|Radiology|2003|895
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877